Friday, November 22

Tag: Pharmacies/Drugstores

Sigma Healthcare Agrees to $5.79 Billion Merger With Pharmacy Chain
11Dec By adminNo Comments
World

Sigma Healthcare Agrees to $5.79 Billion Merger With Pharmacy Chain

SYDNEY—Australian drug supplier Sigma Healthcare agreed to merge with privately owned pharmacy operator CW Group, creating a listed company worth more than 8.8 billion Australian dollars (US$5.79 billion).Sigma on Monday said it would pay A$700 million in cash and issue sufficient new shares for CW Group, the operator of Australia’s prominent Chemist Warehouse pharmacy chain, to own 86% of the combined company. Shareholders of Sigma, which has a market capitalization of A$810.4 million, would own the remainder.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
How a $13.99 Snoopy Sparked a Gen-Z Craze
9Dec By adminNo Comments
World

How a $13.99 Snoopy Sparked a Gen-Z Craze

When Snoopy first appeared in the “Peanuts” comic strip in 1950, his creator Charles M. Schulz couldn’t have guessed that his hand-drawn beagle would spawn one of the hottest toys of 2023.The latest Gen-Z obsession is a $13.99 stuffed Snoopy toy wearing a little blue puffer and a striped hat. A CVS exclusive, the toy is sold out at the pharmacy chain’s locations all over the country. Online, it’s being resold on sites like eBay and Mercari for anywhere between $40 to $70. On Reddit, CVS employees swap stories about receiving dozens of daily phone calls asking if they still have the toy in stock. And on TikTok, young consumers are documenting their quests to get their hands on the stuffed beagle. Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1...
Read More
Cigna, Humana in Talks for Blockbuster Insurance Merger in Stock-and-Cash Deal
30Nov By adminNo Comments
World

Cigna, Humana in Talks for Blockbuster Insurance Merger in Stock-and-Cash Deal

Updated Nov. 29, 2023 4:28 pm ETCigna and Humana are in talks for a combination that would create a new powerhouse in the health-insurance industry. The companies are discussing a stock-and-cash deal that could be finalized by the end of the year, assuming the talks don’t fall apart, according to people familiar with the matter. Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Cigna, Humana in Talks for Blockbuster Merger
29Nov By adminNo Comments
Money

Cigna, Humana in Talks for Blockbuster Merger

Updated Nov. 29, 2023 12:24 pm ETCigna and Humana are in talks for a combination that would create a new powerhouse in the health-insurance industry. The companies are discussing a stock-and-cash deal that could be finalized by the end of the year, assuming the talks don’t fall apart, according to people familiar with the matter. Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Senators Call for Investigation of Health Insurers’ Role in Driving Up Drug Costs
24Nov By adminNo Comments
World

Senators Call for Investigation of Health Insurers’ Role in Driving Up Drug Costs

A pair of U.S. senators called on the federal government to investigate health insurers that are paying high prices for generic drugs for serious diseases like cancer and multiple sclerosis.Sen. Elizabeth Warren (D., Mass.) and Sen. Mike Braun (R., Ind.) sent a letter on Wednesday to the U.S. Department of Health and Human Services’ Office of Inspector General requesting an investigation into the high drug prices and any role played by health insurers’ shared ownership with the pharmacies that often fill the prescriptions.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
These Are the Two Scientists Taking Down Cold Medicine
20Oct By adminNo Comments
World

These Are the Two Scientists Taking Down Cold Medicine

By Nidhi Subbaraman | Photography by Malcolm Jackson for The Wall Street Journal Oct. 20, 2023 12:23 pm ETWhen Leslie Hendeles walked into his neighborhood drugstore this week and learned that a common cold medicine was being pulled off the shelves, he was stunned. The news affirmed a decadeslong quest to steer consumers away from a drug that he long-believed didn’t work.  Hendeles, a retired professor, with his friend, fellow pharmacist and University of Florida professor Randy Hatton, have spent nearly 20 years following the science of phenylephrine, an ingredient in more than 200 over-the-counter decongestants. Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Read More
Rite Aid’s Tactic For Opioid Litigation: Bankruptcy Without A Deal
16Oct By adminNo Comments
World

Rite Aid’s Tactic For Opioid Litigation: Bankruptcy Without A Deal

Oct. 16, 2023 7:27 pm ET|WSJ ProRite Aid appears to be pursuing a novel strategy to handle a huge number of opioid-related lawsuits by sidestepping plaintiffs until after filing for bankruptcy.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8Our Intelligence. Your Advantage.Sign in or subscribe for access to peerless insight & analysis, curated data & interactives, and networking events.
Read More